000			02030 a2200553 4500
005			20250516062731.0
264		0	_c20120313
008			201203s 0 0 eng d
022			_a1095-6859
024	7		_a10.1016/j.ygyno.2011.10.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aHendrickson, Andrea E Wahner
245	0	0	_aA phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. _h[electronic resource]
260			_bGynecologic oncology _cFeb 2012
300			_a210-5 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBenzoquinones _xadministration & dosage
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCarcinoma, Ovarian Epithelial
650	0	4	_aCell Line, Tumor
650	0	4	_aCohort Studies
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHSP70 Heat-Shock Proteins _xmetabolism
650	0	4	_aHSP90 Heat-Shock Proteins _xmetabolism
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms, Glandular and Epithelial _xdrug therapy
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPeritoneal Neoplasms _xdrug therapy
650	0	4	_aSurvival Rate
650	0	4	_aGemcitabine
700	1		_aOberg, Ann L
700	1		_aGlaser, Gretchen
700	1		_aCamoriano, John K
700	1		_aPeethambaram, Prema P
700	1		_aColon-Otero, Gerardo
700	1		_aErlichman, Charles
700	1		_aIvy, S Percy
700	1		_aKaufmann, Scott H
700	1		_aKarnitz, Larry M
700	1		_aHaluska, Paul
773	0		_tGynecologic oncology _gvol. 124 _gno. 2 _gp. 210-5
856	4	0	_uhttps://doi.org/10.1016/j.ygyno.2011.10.002 _zAvailable from publisher's website
999			_c21278065 _d21278065